MONTRÉAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- GURU Organic Energy Corp. (TSX: GURU) (“GURU ” or the “Company ”), Canada’s ...

This assignment extends Bowman’s reach within IDOT and represents the first contract win within Region Two/District Two. Bowman has a strong track record of delivering complex infrastructure projects ...

New non-human primate (NHP) data for VLTR-559, a long-acting anti-VEGF therapy that could reduce the dosing frequency for the treatment of wet ...

Cube Biotech, a pioneer in membrane protein stabilization and purification, and X-Chem, the global leader in DNA-Encoded Library (DEL) technology and data-driven drug discovery, are proud to announce ...

Unlike the traditional two-stage process of sensing and then decision-making, WePilot AiDrive integrates both into a ...

Presentation title : Subretinal gene therapy laru-zova for X-linked retinitis pigmentosa (XLRP): Phase 2 DAWN trial, preliminary month 9+ results Date : Thursday, September 4, 2025 Presenter : Rajiv ...

Season-to-date, the average selling price of office and school supplies is up 1% from last year, and unit sales volume is down 3%. Season-to-date, store brands (private label) gained market share, ...

With this milestone, VG801 now holds RMAT, Rare Pediatric Disease, and Orphan Drug designations. VeonGen has also been selected to collaborate with the FDA under the Rare Disease Endpoint Advancement ...

Dr. Emory De Castro, PhD, Advent’s Chief Technology Officer, stated, “The ability to produce a gas sensor on a chip offers an array of possibilities including the addition of sensing capabilities to ...

Aaron is a seasoned energy executive with over two decades of experience driving innovation, strategic growth, and large-scale project delivery across the solar and energy storage sectors. His ...

Vafseo was approved by the U.S. Food and Drug Administration (FDA) in March 2024 for the treatment of anemia due to CKD in adults who have been receiving dialysis for at least three months. The ...

About LockeT Catheter Precision’s LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and ...